This murine study examined how peripheral sensing of viral dsRNA (via footpad injection of a mimic) triggers a systemic type I interferon (IFN-I) response that establishes an antiviral state in the brain, focusing on the role of brain microvascular endothelial cells (BMECs) across multiple neurotropic viruses (West Nile virus and others from Orthoflaviviridae, Togaviridae, and Orthoherpesviridae).
Peripheral viral pattern sensing drove robust IFN-I-stimulated gene expression in the brain; BMEC IFN-I receptor signaling was the critical node in this inter-organ crosstalk, and activating this pathway protected mice against lethal encephalitis from multiple neurotropic virus families.
All mechanistic data are from murine models, limiting direct translation to human CNS disease; the study uses a dsRNA mimic rather than natural infection to decouple sensing from replication, which may not fully recapitulate in vivo dynamics; therapeutic applicability to emerging human pathogens remains speculative.
These findings identify brain endothelial IFN-I signaling as a potential therapeutic target for viral encephalitis. Strategies that boost systemic IFN-I or its receptor signaling at the blood-brain barrier may one day reduce severity of encephalitis from emerging arboviruses, though this requires validation in human models.
Explore related topics
